Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC

Clinical trial NCT06609876 · RECRUITING

Trial details

NCT number: NCT06609876
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Microwave Ablation Donafenib Recurrent Tumor

Start date: 2024-10-01
Primary completion: 2026-10-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.